Macquarie Group LTD Intercept Pharmaceuticals, Inc. Transaction History

Macquarie Group LTD

$85.1 Billion
Q2 2024

24 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 14, 2023	SELL	$9.17 - $19.29 $6.05 Million - $12.7 Million	-659,267 Reduced 96.07%	27,000 $298,000
Q1 2023 May 15, 2023	BUY	$12.53 - $21.71 $178,828 - $309,845	14,272 Added 2.12%	686,267 $9.22 Million
Q4 2022 Feb 21, 2023	BUY	$11.61 - $16.11 $186,398 - $258,646	16,055 Added 2.45%	671,995 $8.31 Million
Q3 2022 Nov 14, 2022	BUY	$12.21 - $19.7 $132,734 - $214,158	10,871 Added 1.69%	655,940 $9.16 Million
Q2 2022 Aug 15, 2022	BUY	$11.23 - $19.59 $273,989 - $477,956	24,398 Added 3.93%	645,069 $8.91 Million
Q1 2022 May 16, 2022	BUY	$13.37 - $17.79 $42,436 - $56,465	3,174 Added 0.51%	620,671 $10.1 Million
Q4 2021 Feb 11, 2022	SELL	$14.28 - $19.53 $55,906 - $76,459	-3,915 Reduced 0.63%	617,497 $10.1 Million
Q3 2021 Nov 12, 2021	SELL	$12.99 - $20.47 $711,826 - $1.12 Million	-54,798 Reduced 8.1%	621,412 $9.23 Million
Q2 2021 Aug 13, 2021	BUY	$15.46 - $24.5 $161,526 - $255,976	10,448 Added 1.57%	676,210 $13.5 Million
Q1 2021 May 14, 2021	SELL	$19.33 - $37.75 $752,362 - $1.47 Million	-38,922 Reduced 5.52%	665,762 $15.4 Million
Q4 2020 Feb 16, 2021	SELL	$24.48 - $42.47 $1.82 Million - $3.15 Million	-74,275 Reduced 9.54%	704,684 $17.4 Million
Q3 2020 Nov 13, 2020	BUY	$39.09 - $53.44 $426,667 - $583,297	10,915 Added 1.42%	778,959 $32.3 Million
Q2 2020 Aug 11, 2020	BUY	$46.7 - $92.04 $2.47 Million - $4.86 Million	52,830 Added 7.39%	768,044 $36.8 Million
Q1 2020 May 15, 2020	BUY	$48.35 - $118.68 $8.21 Million - $20.2 Million	169,800 Added 31.13%	715,214 $45 Million
Q4 2019 Feb 14, 2020	BUY	$57.36 - $124.1 $10.5 Million - $22.7 Million	183,072 Added 50.52%	545,414 $67.6 Million
Q3 2019 Nov 14, 2019	BUY	$58.69 - $80.46 $19 Million - $26 Million	322,971 Added 820.33%	362,342 $24 Million
Q2 2019 Aug 14, 2019	BUY	$77.77 - $120.68 $162,228 - $251,738	2,086 Added 5.59%	39,371 $3.13 Million
Q1 2019 May 15, 2019	BUY	$91.83 - $120.68 $69,607 - $91,475	758 Added 2.08%	37,285 $4.17 Million
Q4 2018 Feb 15, 2019	BUY	$85.79 - $126.46 $82,873 - $122,160	966 Added 2.72%	36,527 $3.68 Million
Q3 2018 Nov 15, 2018	BUY	$88.49 - $127.55 $1.93 Million - $2.78 Million	21,819 Added 158.78%	35,561 $4.49 Million
Q2 2018 Aug 14, 2018	BUY	$60.0 - $85.67 $243,720 - $347,991	4,062 Added 41.96%	13,742 $1.15 Million
Q1 2018 May 11, 2018	SELL	$52.72 - $67.25 $4,639 - $5,918	-88 Reduced 0.9%	9,680 $596,000
Q4 2017 Feb 15, 2018	BUY	$58.2 - $72.76 $277,497 - $346,919	4,768 Added 95.36%	9,768 $571,000
Q3 2017 Nov 08, 2017	BUY	$57.01 - $118.75 $285,050 - $593,750	5,000	5,000 $290,000

Others Institutions Holding ICPT

# of Institutions

Shares Held

1.04M

Call Options Held

30K

Put Options Held

5.9K

View Full List

About INTERCEPT PHARMACEUTICALS, INC.

Ticker ICPT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 41,127,400
Description
Intercept Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development and commercialization of therapeutics to treat progressive non-viral liver diseases in the United States, Europe, and Canada. The company markets Ocaliva, a farnesoid X receptor agonist used for the treatment of primary biliary cholangitis in combination wit...

More about ICPT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Macquarie Group LTD, based on Form 13F filings with the SEC.

News

Stay updated on Macquarie Group LTD with notifications on news.

Account